Depreciation of Medpace Holdings, Inc. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Medpace Holdings, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • Medpace Holdings, Inc. Depreciation for the quarter ending 31 Dec 2025 was $6,894,000, a 3.5% decline year-over-year.
  • Medpace Holdings, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $27,178,000, a 2.3% decline year-over-year.
  • Medpace Holdings, Inc. annual Depreciation for 2025 was $27,178,000, a 2.3% decline from 2024.
  • Medpace Holdings, Inc. annual Depreciation for 2024 was $27,808,000, a 15% increase from 2023.
  • Medpace Holdings, Inc. annual Depreciation for 2023 was $24,129,000, a 27% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $27,178,000 $6,894,000 -$251,000 -3.5% 01 Oct 2025 31 Dec 2025 10-K 10 Feb 2026 2025 FY
Q3 2025 $27,429,000 $6,813,000 -$345,000 -4.8% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $27,774,000 $6,777,000 -$97,000 -1.4% 01 Apr 2025 30 Jun 2025 10-Q 22 Jul 2025 2025 Q2
Q1 2025 $27,871,000 $6,694,000 +$63,000 +0.95% 01 Jan 2025 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 $27,808,000 $7,145,000 +$723,000 +11% 01 Oct 2024 31 Dec 2024 10-K 10 Feb 2026 2025 FY
Q3 2024 $27,085,000 $7,158,000 +$829,000 +13% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025 2025 Q3
Q2 2024 $26,256,000 $6,874,000 +$904,000 +15% 01 Apr 2024 30 Jun 2024 10-Q 22 Jul 2025 2025 Q2
Q1 2024 $25,352,000 $6,631,000 +$1,223,000 +23% 01 Jan 2024 31 Mar 2024 10-Q 22 Apr 2025 2025 Q1
Q4 2023 $24,129,000 $6,422,000 +$1,361,000 +27% 01 Oct 2023 31 Dec 2023 10-K 10 Feb 2026 2025 FY
Q3 2023 $22,768,000 $6,329,000 +$1,378,000 +28% 01 Jul 2023 30 Sep 2023 10-Q 22 Oct 2024 2024 Q3
Q2 2023 $21,390,000 $5,970,000 +$1,263,000 +27% 01 Apr 2023 30 Jun 2023 10-Q 23 Jul 2024 2024 Q2
Q1 2023 $20,127,000 $5,408,000 +$1,138,000 +27% 01 Jan 2023 31 Mar 2023 10-Q 23 Apr 2024 2024 Q1
Q4 2022 $18,989,000 $5,061,000 +$875,000 +21% 01 Oct 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
Q3 2022 $18,114,000 $4,951,000 +$895,000 +22% 01 Jul 2022 30 Sep 2022 10-Q 24 Oct 2023 2023 Q3
Q2 2022 $17,219,000 $4,707,000 +$756,000 +19% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023 2023 Q2
Q1 2022 $16,463,000 $4,270,000 +$458,000 +12% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023 2023 Q1
Q4 2021 $16,005,000 $4,186,000 +$652,000 +18% 01 Oct 2021 31 Dec 2021 10-K 13 Feb 2024 2023 FY
Q3 2021 $15,353,000 $4,056,000 +$1,065,000 +36% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022 2022 Q3
Q2 2021 $14,288,000 $3,951,000 +$1,277,000 +48% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022 2022 Q2
Q1 2021 $13,011,000 $3,812,000 +$1,359,000 +55% 01 Jan 2021 31 Mar 2021 10-Q 26 Apr 2022 2022 Q1
Q4 2020 $11,652,000 $3,534,000 +$1,209,000 +52% 01 Oct 2020 31 Dec 2020 10-K 14 Feb 2023 2022 FY
Q3 2020 $10,443,000 $2,991,000 +$929,000 +45% 01 Jul 2020 30 Sep 2020 10-Q 26 Oct 2021 2021 Q3
Q2 2020 $9,514,000 $2,674,000 +$692,000 +35% 01 Apr 2020 30 Jun 2020 10-Q 27 Jul 2021 2021 Q2
Q1 2020 $8,822,000 $2,453,000 +$462,000 +23% 01 Jan 2020 31 Mar 2020 10-Q 27 Apr 2021 2021 Q1
Q4 2019 $8,360,000 $2,325,000 -$32,000 -1.4% 01 Oct 2019 31 Dec 2019 10-K 15 Feb 2022 2021 FY
Q3 2019 $8,392,000 $2,062,000 -$281,000 -12% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020 2020 Q3
Q2 2019 $8,673,000 $1,982,000 -$244,000 -11% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020 2020 Q2
Q1 2019 $8,917,000 $1,991,000 -$323,000 -14% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q4 2018 $9,240,000 $2,357,000 +$251,000 +12% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
Q3 2018 $8,989,000 $2,343,000 +$106,000 +4.7% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019 2019 Q3
Q2 2018 $8,883,000 $2,226,000 +$125,000 +6% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2019 Q2
Q1 2018 $8,758,000 $2,314,000 +$184,000 +8.6% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
Q4 2017 $8,574,000 $2,106,000 +$145,000 +7.4% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
Q3 2017 $8,429,000 $2,237,000 +$322,000 +17% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018 2018 Q3
Q2 2017 $8,107,000 $2,101,000 +$308,000 +17% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2018 Q2
Q1 2017 $7,799,000 $2,130,000 +$357,000 +20% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018 2018 Q1
Q4 2016 $7,442,000 $1,961,000 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
Q3 2016 $1,915,000 +$304,000 +19% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017 2017 Q3
Q2 2016 $1,793,000 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2017 Q2
Q1 2016 $1,773,000 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017 2017 Q1
Q3 2015 $1,611,000 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2016 Q3

Medpace Holdings, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $27,178,000 -$630,000 -2.3% 01 Jan 2025 31 Dec 2025 10-K 10 Feb 2026 2025 FY
2024 $27,808,000 +$3,679,000 +15% 01 Jan 2024 31 Dec 2024 10-K 10 Feb 2026 2025 FY
2023 $24,129,000 +$5,140,000 +27% 01 Jan 2023 31 Dec 2023 10-K 10 Feb 2026 2025 FY
2022 $18,989,000 +$2,984,000 +19% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025 2024 FY
2021 $16,005,000 +$4,353,000 +37% 01 Jan 2021 31 Dec 2021 10-K 13 Feb 2024 2023 FY
2020 $11,652,000 +$3,292,000 +39% 01 Jan 2020 31 Dec 2020 10-K 14 Feb 2023 2022 FY
2019 $8,360,000 -$880,000 -9.5% 01 Jan 2019 31 Dec 2019 10-K 15 Feb 2022 2021 FY
2018 $9,240,000 +$666,000 +7.8% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 $8,574,000 +$1,132,000 +15% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $7,442,000 +$1,063,000 +17% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $6,379,000 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.